Scientometrics
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 14, 2023; 29(42): 5781-5799
Published online Nov 14, 2023. doi: 10.3748/wjg.v29.i42.5781
Research status and hotspots of autoimmune gastritis: A bibliometric analysis
Yun-Feng Yu, Ke-Ke Tong, Xue-Li Shangguan, Xin-Yu Yang, Jing-Yi Wu, Gang Hu, Rong Yu, Chuan-Chuan Tan
Yun-Feng Yu, Xue-Li Shangguan, Gang Hu, Rong Yu, Chuan-Chuan Tan, The First Hospital, Hunan University of Chinese Medicine, Changsha 410007, Hunan Province, China
Ke-Ke Tong, The Hospital of Hunan University of Traditional Chinese Medicine, Hunan University of Traditional Chinese Medicine, Changde 415213, Hunan Province, China
Xin-Yu Yang, College of Chinese Medicine, Hunan University of Chinese Medicine, Changsha 410208, Hunan Province, China
Jing-Yi Wu, The Third Hospital, Zhejiang Chinese Medical University, Hangzhou 310005, Zhejiang Province, China
Co-first authors: Yun-Feng Yu and Ke-Ke Tong.
Author contributions: Yu YF conceived and designed the study; Yu YF and Tong KK participated in data processing and statistical analysis; Yu YF, Tong KK, Wu JY, and Shangguan XL drafted the manuscript; Shangguan XL, Yang XY, Hu G, Tan CC, and Wu JY contributed to data analysis and interpretation; Yu YF, Tong KK, Yang XY, Yu R, and Tan CC supervised the review of the study; All authors seriously revised and approved the final manuscript. Yu YF and Tong KK contributed equally to this work as co-first authors. The reasons for designating Yu YF and Tong KK as co-first authors are threefold. First, the research was performed as a collaborative effort, and the designation of co-first authorship accurately reflects the distribution of responsibilities and burdens associated with the time and effort required to complete the study and the resultant paper. This also ensures effective communication and management of post-submission matters, ultimately enhancing the paper’s quality and reliability. Second, the overall research team encompassed authors with a variety of expertise and skills from different fields, and the designation of co-first authors best reflects this diversity. Third, Yu YF and Tong KK contributed efforts of equal substance throughout the research process. The choice of these researchers as co-first authors acknowledges and respects this equal contribution, while recognizing the spirit of teamwork and collaboration of this study. In summary, we believe that designating Yu YF and Tong KK as co-first authors of is fitting for our manuscript as it accurately reflects our team’s collaborative spirit, equal contributions, and diversity.
Supported by National Natural Science Foundation of China, NO. U21A20411.
Conflict-of-interest statement: Dr. Tan has nothing to disclose.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Chuan-Chuan Tan, Doctor, The First Hospital, Hunan University of Chinese Medicine, No.95 Shaoshan Middle Road, Yuhua District, Changsha 410007, Hunan Province, China. cchuan16@hotmail.com
Received: September 20, 2023
Peer-review started: September 20, 2023
First decision: October 7, 2023
Revised: October 18, 2023
Accepted: October 30, 2023
Article in press: October 30, 2023
Published online: November 14, 2023
Processing time: 53 Days and 23.1 Hours
ARTICLE HIGHLIGHTS
Research background

Autoimmune gastritis (AIG) is a distinctive type of chronic atrophic gastritis that is considered a potential risk factor for some tumors. Increasing numbers of researchers are focusing on the pathogenesis, diagnosis, and prognosis of AIG.

Research motivation

Bibliometrics is one of the most commonly used methods to evaluate the research status in a field. To date, there are no bibliometric studies related to AIG. Bibliometric analysis provide a more comprehensive overview of the research status and research hotspots in AIG.

Research objectives

This study aims to provide a comprehensive understanding of the knowledge structure and research hotspots of AIG and to offer new ideas and directions for its research.

Research methods

Data for this study were sourced from the Web of Science Core Collection. The proposed search formula was “translational science = Autoimmune gastritis OR Autoimmune atrophic gastritis”. The search was conducted until May 2023, the restricted language was English, and the type of studies included were articles and review articles.

Research results

In total, 316 relevant articles were included. From 2015 to 2022, the number of publications increased annually. The countries, institutions, authors, and journals with the highest number of publications in this field were Italy, Monash University, Toh BH, and Internal Medicine. The main keywords usd in this field of research were pathogenesis, Helicobacter pylori, autoantibody, parietal cell antibody, atrophic gastritis, classification, diagnosis, autoimmune disease, risk, cancer, gastric cancer, vitamin B12 deficiency, and pernicious anemia.

Research conclusions

This was the first bibliometric analysis related to AIG, highlighting hot topics and emerging trends in the field, and offering new ideas to further scientific research and clinical applications.

Research perspectives

The following directions may be popular for future research: (1) The role of Helicobacter pylori in the pathogenesis of AIG; (2) diagnostic criteria for AIG and the reference value of serum antibodies; (3) comorbidity mechanisms between AIG and other autoimmune diseases; (4) specific risks of AIG complicating gastric and other cancers; and (5) the role of vitamin B12 supplementation in patients with early-stage AIG.